KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Operating Leases (2019 - 2025)

Charles River Laboratories International has reported Operating Leases over the past 7 years, most recently at $434.0 million for Q4 2025.

  • For Q4 2025, Operating Leases fell 10.28% year-over-year to $434.0 million; the TTM value through Dec 2025 reached $434.0 million, down 10.28%, while the annual FY2025 figure was $434.0 million, 10.28% down from the prior year.
  • Operating Leases for Q4 2025 was $434.0 million at Charles River Laboratories International, down from $443.2 million in the prior quarter.
  • Over five years, Operating Leases peaked at $483.8 million in Q4 2024 and troughed at $173.0 million in Q1 2021.
  • A 5-year average of $383.2 million and a median of $418.1 million in 2023 define the central range for Operating Leases.
  • Biggest five-year swings in Operating Leases: soared 84.07% in 2021 and later fell 10.28% in 2025.
  • Year by year, Operating Leases stood at $286.2 million in 2021, then skyrocketed by 52.41% to $436.3 million in 2022, then increased by 8.68% to $474.1 million in 2023, then increased by 2.03% to $483.8 million in 2024, then decreased by 10.28% to $434.0 million in 2025.
  • Business Quant data shows Operating Leases for CRL at $434.0 million in Q4 2025, $443.2 million in Q3 2025, and $453.7 million in Q2 2025.